Saudi Arabia : Guidelines for Stability Testing of New Drug Substances and Products:
The following guideline defines the stability data package for a drug substance or drug product that is sufficient for registration within the Kingdom of Saudi Arabia (K.S.A).
The guideline seeks to exemplify the core stability data package for drug substance or drug products, but leaves sufficient flexibility to encompass the variety of different practical situations that may be encountered due to specific scientific considerations and characteristics of the materials being evaluated. Alternative approaches may be used when there are scientifically justifiable reasons.